BIOPHTA

French tech company | Builders Republic

About

Biotech company developing self-administered mucoadhesive ophthalmic inserts — dry tablets built on a patented thiomer biopolymer platform that turn into gel on the eye and release the drug continuously, to replace daily eye drops and intraocular injections in glaucoma and macular oedema.

Key facts

Status
Active
Sectors
Healthcare & Life Sciences
Latest stage
Seed
Founded
2020
City
RENNES
Region
Bretagne
Tracked rounds
1
Amount raised
6.5 M€

Operations

  • Seed · 2024

Investors